Rituximab after autologous stem cell transplantation in mantle cell lymphoma patients prolongs survival
1. Patients with mantle cell lymphoma treated with autologous stem cell transplantation experienced greater overall, event-free, and progression-free survival when ...





![Improved hematologic cancer survival in Europe over a 15 year period [EUROCARE-5 study]](https://www.2minutemedicine.com/wp-content/uploads/2014/07/700px-Europe_polar_stereographic_Caucasus_Urals_boundary.svg_-350x250.png)



